Cite
CD4 + T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein.
MLA
Taborska, Pavla, et al. “CD4 + T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein.” Frontiers in Immunology, vol. 12, May 2021, p. 629102. EBSCOhost, https://doi.org/10.3389/fimmu.2021.629102.
APA
Taborska, P., Strizova, Z., Stakheev, D., Sojka, L., Bartunkova, J., & Smrz, D. (2021). CD4 + T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein. Frontiers in Immunology, 12, 629102. https://doi.org/10.3389/fimmu.2021.629102
Chicago
Taborska, Pavla, Zuzana Strizova, Dmitry Stakheev, Ludek Sojka, Jirina Bartunkova, and Daniel Smrz. 2021. “CD4 + T Cells of Prostate Cancer Patients Have Decreased Immune Responses to Antigens Derived From SARS-CoV-2 Spike Glycoprotein.” Frontiers in Immunology 12 (May): 629102. doi:10.3389/fimmu.2021.629102.